Medwell Capital Provides Listing Update

EDMONTON, Sept. 7 /CNW/ - Medwell Capital Corp. (TSX: MWC) today announced that, further to recent discussions with the Toronto Stock Exchange (the "TSX"), it will be proceeding with a voluntary delisting of its Class A common shares from the TSX and have applied for a listing of its Class A common shares on the TSX Venture Exchange ("TSXV"). The precise timing of the delisting from the TSX and the planned listing on the TSXV are not yet known and Medwell will make a further announcement when those details are available.

The Company expects there to be a seamless transition of the listing of its Class A common shares to the TSXV and no disruption to the trading environment for its shareholders.

    
    About Medwell Capital Corp.
    ---------------------------
    

Medwell Capital Corp. is a Canadian-based service provider in the healthcare industry. For further information please visit www.medwellcapital.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Corporation's ongoing quarterly and annual reporting. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For further information: Tony Hesby, Ryan Giese, Medwell Capital Corp., 780-413-7152, 780-408-3040 Fax, E-mail: [email protected], Internet: http://www.medwellcapital.com; James Smith, Investor Relations, 416-815-0700 ext. 229, 416-815-0080 Fax, E-mail: [email protected]